Now that the House has passed its version of tax reform, the Senate is eyeing a vote on its own tax bill the week after Thanksgiving. It's about time for health-care stakeholders to take the implications of this effort seriously.
Of particular note in this context is the repeal of the Affordable Care Act's individual mandate, which the Senate has proposed as an offset, providing over $300 billion in savings due to millions fewer individuals receiving subsidized health insurance. Additionally, a rarely discussed provision in congressional PAYGO rules could require over $135 billion in annual cuts to mandatory spending, targeting health-care programs including Medicare and ACA funding. Furthermore, changes to the medical expense deduction and orphan drug tax credit are both on the table, each of which would have notable consequences across health-care industries.